Archive: 05/06/2017
Dasatinib excels in worldwide phase II trial against pediatric CML
In 2002, the FDA approved the drug imatinib as a first-line therapy for adults with chronic myeloid leukemia (CML) caused by the fusion gene BCR-ABL, known as the Philadelphia chromosome. The approval dramatically extended ...
Jun 5, 2017
A single radiation treatment sufficiently relieves spinal cord compression symptoms
"Spinal cord compression is a debilitating condition that many patients with advanced cancer experience. Until now, patients often had to spend multiple days traveling back and forth to undergo radiation treatments. This ...
Jun 5, 2017